Literature DB >> 21246370

Circulating endothelial progenitor cells are reduced in SLE in the absence of coronary artery calcification.

Joshua F Baker1, Lifeng Zhang, Sotonye Imadojemu, Alexis Sharpe, Sarita Patil, Jonni S Moore, Emile R Mohler, Joan Von Feldt.   

Abstract

Circulating endothelial progenitor cells (EPCs) are reduced in patients with systemic lupus erythematosus (SLE). A reduced number of EPCs are associated with the presence of atherosclerosis in other populations. We sought to determine whether the reduction in EPC numbers in SLE is dependent on the presence of advanced coronary artery calcification (CAC). Patients with SLE had previous coronary calcium scores which placed them in either the >75th percentile or <25th percentile for their age. Seventeen patients with SLE and 13 healthy controls (HC) were included in the study. White blood cells were stained for EPC and progenitor cell markers including CD34, CD133, and VEGFR and analyzed by flow cytometry. SLE patients had repeated coronary imaging as well as carotid ultrasound. There was no difference in age between groups. SLE patients with advanced CAC were more likely to be hypertensive, to be smokers, and to have longer disease duration than SLE patients without CAC. SLE patients without evidence of CAC had a significantly lower number of EPCs (CD34+/CD133+/VEGFR+) compared to HC (median (IQR)) 0 (0, 6.7) vs. 10.2 (5.8, 12.3) (P = 0.02). Total numbers of PCs (CD133+/CD34+) were not significantly decreased in patients with SLE ((mean ± SEM) 1,007 ± 154 vs. 824 ± 170 (P = 0.20)). No significant difference was seen in EPC number between SLE patients without CAC and those with advanced CAC. Increased carotid intima-media thickness did not correlate with CAC or EPC number in SLE patients. Reduced numbers of EPCs in SLE patients may be observed compared to HC even in the absence of CAC. Differences in measured risk factor profiles and depletion of total circulating PCs do not fully explain this finding.

Entities:  

Mesh:

Year:  2011        PMID: 21246370     DOI: 10.1007/s00296-010-1730-9

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  23 in total

Review 1.  Modern flow cytometry: a practical approach.

Authors:  James W Tung; Kartoosh Heydari; Rabin Tirouvanziam; Bita Sahaf; David R Parks; Leonard A Herzenberg; Leonore A Herzenberg
Journal:  Clin Lab Med       Date:  2007-09       Impact factor: 1.935

Review 2.  Premature atherosclerotic cardiovascular disease in systemic lupus erythematosus.

Authors:  Peter E Westerweel; Remco K M A C Luyten; Hein A Koomans; Ronald H W M Derksen; Marianne C Verhaar
Journal:  Arthritis Rheum       Date:  2007-05

Review 3.  Endothelial progenitor cells: novel players in the pathogenesis of rheumatic diseases.

Authors:  Jörg H W Distler; Christian Beyer; Georg Schett; Thomas F Lüscher; Steffen Gay; Oliver Distler
Journal:  Arthritis Rheum       Date:  2009-11

4.  The association of coronary artery calcification and carotid artery intima-media thickness with distinct, traditional coronary artery disease risk factors in asymptomatic adults.

Authors:  Evadnie Rampersaud; Lawrence F Bielak; Afshin Parsa; Haiqing Shen; Wendy Post; Kathleen A Ryan; Patrick Donnelly; John A Rumberger; Patrick F Sheedy; Patricia A Peyser; Alan R Shuldiner; Braxton D Mitchell
Journal:  Am J Epidemiol       Date:  2008-09-19       Impact factor: 4.897

5.  Circulating endothelial progenitor cells and cardiovascular outcomes.

Authors:  Nikos Werner; Sonja Kosiol; Tobias Schiegl; Patrick Ahlers; Katrin Walenta; Andreas Link; Michael Böhm; Georg Nickenig
Journal:  N Engl J Med       Date:  2005-09-08       Impact factor: 91.245

6.  Peripheral blood MDS score: a new flow cytometric tool for the diagnosis of myelodysplastic syndromes.

Authors:  Sindhu Cherian; Jonni Moore; Andrew Bantly; Jo-Anne Vergilio; Peter Klein; Selina Luger; Adam Bagg
Journal:  Cytometry B Clin Cytom       Date:  2005-03       Impact factor: 3.058

7.  Flow cytometric measurement of circulating endothelial cells: the effect of age and peripheral arterial disease on baseline levels of mature and progenitor populations.

Authors:  Rebecca Gusic Shaffer; Sam Greene; Arash Arshi; Greg Supple; Andrew Bantly; Jonni S Moore; Emile R Mohler
Journal:  Cytometry B Clin Cytom       Date:  2006-03       Impact factor: 3.058

8.  Isolation of putative progenitor endothelial cells for angiogenesis.

Authors:  T Asahara; T Murohara; A Sullivan; M Silver; R van der Zee; T Li; B Witzenbichler; G Schatteman; J M Isner
Journal:  Science       Date:  1997-02-14       Impact factor: 47.728

9.  Systemic lupus erythematosus patients exhibit functional deficiencies of endothelial progenitor cells.

Authors:  J Grisar; C W Steiner; M Bonelli; T Karonitsch; I Schwarzinger; G Weigel; G Steiner; J S Smolen
Journal:  Rheumatology (Oxford)       Date:  2008-07-26       Impact factor: 7.580

10.  Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis.

Authors:  Michael F Denny; Seth Thacker; Hemal Mehta; Emily C Somers; Todd Dodick; Franck J Barrat; W Joseph McCune; Mariana J Kaplan
Journal:  Blood       Date:  2007-07-16       Impact factor: 25.476

View more
  8 in total

Review 1.  Coronary artery calcium scoring and its impact on the clinical practice in the era of multidetector CT.

Authors:  Jongmin Lee
Journal:  Int J Cardiovasc Imaging       Date:  2011-10-20       Impact factor: 2.357

Review 2.  Arterial calcification: Finger-pointing at resident and circulating stem cells.

Authors:  Francesco Vasuri; Silvia Fittipaldi; Gianandrea Pasquinelli
Journal:  World J Stem Cells       Date:  2014-11-26       Impact factor: 5.326

Review 3.  Endothelial function and endothelial progenitor cells in systemic lupus erythematosus.

Authors:  Anselm Mak; Jerry Kok Yen Chan
Journal:  Nat Rev Rheumatol       Date:  2022-04-07       Impact factor: 20.543

Review 4.  Endothelial progenitor cells: a new player in lupus?

Authors:  Sahena Haque; M Yvonne Alexander; Ian N Bruce
Journal:  Arthritis Res Ther       Date:  2012-02-20       Impact factor: 5.156

Review 5.  Activation of type I interferon pathway in systemic lupus erythematosus: association with distinct clinical phenotypes.

Authors:  Theophanis P Karageorgas; Dimitrios D Tseronis; Clio P Mavragani
Journal:  J Biomed Biotechnol       Date:  2011-11-16

Review 6.  IFN-I Mediates Dysfunction of Endothelial Progenitor Cells in Atherosclerosis of Systemic Lupus Erythematosus.

Authors:  Xuewei Ding; Wei Xiang; Xiaojie He
Journal:  Front Immunol       Date:  2020-11-11       Impact factor: 7.561

7.  B lymphocyte stimulator modulates number and function of endothelial progenitor cells in systemic lupus erythematosus.

Authors:  Francesca Romana Spinelli; Cristiana Barbati; Fulvia Cecarelli; Francesca Morello; Tania Colasanti; Marta Vomero; Laura Massaro; Valeria Orefice; Cristiano Alessandri; Guido Valesini; Fabrizio Conti
Journal:  Arthritis Res Ther       Date:  2019-11-21       Impact factor: 5.156

8.  The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus.

Authors:  Alessandra Bortoluzzi; Cecilia Beatrice Chighizola; Micaela Fredi; Elena Raschi; Caterina Bodio; Daniela Privitera; Arianna Gonelli; Ettore Silvagni; Marcello Govoni; Ilaria Cavazzana; Paolo Airò; Pier Luigi Meroni; Angela Tincani; Franco Franceschini; Silvia Piantoni; Fabio Casciano
Journal:  Front Immunol       Date:  2020-10-29       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.